NDC0221-1356-50: THEOPHYLLINE EXTENDED-RELEASE CA.
THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include capsule_type: HARD, special_features: LONG ACTION METHOD:EXTENDED RELEASE;, capsule_content_form: PELLET, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-064-9555, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| capsule_type | HARD |
| special_features | LONG ACTION METHOD:EXTENDED RELEASE; |
| capsule_content_form | PELLET |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-01-064-9555 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | LONG ACTION METHOD:EXTENDED RELEASE; |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| CAPSULE TYPE | HARD |
| CAPSULE CONTENT FORM | PELLET |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |